Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Rangering i aksjer #38483
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Aksjekurs
$0.01142111
Sist synkronisert: 2025-03-21
Markedsverdi
$930.66K
Endring (1 dag)
0.18%
Endring (1 år)
-69.73%
Land
IE
Handel Ovoca Bio plc (OVXA)

Kategori

Inntekter for Ovoca Bio plc (OVXA)
Inntekter i Jun 2024 TTM: $-5.54M
Ifølge Ovoca Bio plc sine nyeste økonomiske rapporter er selskapets nåværende resultat $-5.54M. I 2023 hadde selskapet et resultat på $-5.64M, en økning sammenlignet med resultatet i 2022, som var $-6.02M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Ovoca Bio plc fra 2001 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-5.54M 177,402.36%
2024 $-3.12K -99.94%
2023 $-5.64M -6.27%
2022 $-6.02M 0.89%
2021 $-5.97M 111.35%
2020 $-2.82M 32.29%
2019 $-2.13M -6.96%
2018 $-2.29M 401.73%
2017 $-457.16K -54.69%
2016 $-1.01M -58.18%
2015 $-2.41M -69.99%
2014 $-8.04M -60.54%
2013 $-20.37M 592.33%
2012 $-2.94M -153.33%
2011 $5.52M 340.98%
2010 $1.25M -87.44%
2009 $9.96M -683.08%
2008 $-1.71M 36.71%
2007 $-1.25M -81.83%
2006 $-6.88M 549.04%
2005 $-1.06M 285.00%
2004 $-275.29K 10.93%
2003 $-248.17K 96.02%
2002 $-126.60K -32.76%
2001 $-188.29K 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$5.27B -95,296.05%
US
$1.95B -35,303.36%
NL
$-3.09B 55,611.05%
US
$-4.02B 72,380.25%
AU
- -
CH